Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Touchlight IP Limited currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single action is concentrated under 1 distinct examiner and 1 distinct art unit, indicating a highly focused prosecution footprint at this stage of the company's patent filings. Because the entire active workload is confined to 1 administrative unit, the company's current interactions with the patent office are centralized, which allows for the tracking of deadlines and examiner communications within this specific portfolio to remain focused.
The busiest examiner for the portfolio is YAMASAKI, ROBERT J, who is responsible for 1 busiest examiner pending office action. Because the total pending office actions and the busiest examiner pending count both equal 1, this specific examiner handles the entirety of the company's current workload before the office. This relationship between the total actions and those assigned to the busiest examiner means that the prosecution strategy for the company's pending matters is currently dependent on the review of 1 individual. For practitioners, this concentration suggests that understanding the specific preferences and historical trends of YAMASAKI, ROBERT J is a primary consideration, as there are no other distinct examiners or art units currently influencing the portfolio's pending outcomes.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YAMASAKI, ROBERT J | 1 | 67.6% | +43.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17799353 | DNA SYNTHESIS YIELD IMPROVEMENTS | YAMASAKI, ROBERT J | — |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17799353 | DNA SYNTHESIS YIELD IMPROVEMENTS | YAMASAKI, ROBERT J | 1657 | §103§112DP | Non-Final OA | — | Pending | Aug 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial